CB Therapeutics Revolutionizes Color and Antioxidant Production: Precision Fermentation Sets New Standard for Cost-Efficiency and Sustainability
April 17 2024 - 10:00AM
Business Wire
CB Therapeutics (the “Company”), a frontrunner in biotechnology
and precision fermentation, announces a monumental stride towards
sustainability with the introduction of natural food and product
colors, coupled with potent antioxidants. This innovative leap not
only transforms coloration and nutrition but also sets a new
benchmark for environmental responsibility in the food and
industrial sectors.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240415387825/en/
(Photo: Business Wire)
Harnessing the transformative potential of precision
fermentation, CB Therapeutics unveils a vibrant palette of natural
colors, including striking orange from carrots (β-carotene), deep
purple from beets (betalains), bold red from tomatoes (lycopene),
sunny yellow from marigolds (lutein), and more. The synergy of
these hues offers an extensive array of colors, catering to diverse
consumer demands and industrial applications.
Beyond their aesthetic allure, these natural molecules serve as
vital antioxidants and nutrients, fortifying cells against harmful
free radicals and bolstering overall health. The adoption of CB
Therapeutics' innovative solutions not only elevates product
quality but also reinforces a commitment to consumer well-being and
environmental stewardship, emphasized Sher Ali Butt, Co-Founder and
CEO of CB Therapeutics.
Jacob Vogan, Co-Founder and CSO of CB Therapeutics, added that
“in stark contrast to conventional methods, which often entail
exorbitant costs, lengthy processes, and yield significant
environmental repercussions, precision fermentation offers a
sustainable and efficient alternative. By utilizing precision
fermentation, CB Therapeutics significantly reduces carbon
emissions, with estimates suggesting a reduction of metric tons of
CO2 annually compared to traditional color production methods.”
CB Therapeutics is now looking to collaborate with partners in
need of these sustainable colors. Interested companies should reach
out to our CEO at sher@cbthera.com.
About CB Therapeutics
CB Therapeutics' expertise in synthetic genomics and
bio-engineering has significantly advanced its proprietary
production platform of microorganisms, enzymes, and production
processes. After more than nine years of research and development,
the CB Therapeutics team can produce a broad range of
phytochemicals faster, utilizing fewer resources, at greater
yields, and with more purity, consistency, and efficiency than
competing platforms. CB Therapeutics operates from their new 16,000
sq. ft. facility in southern California.
Follow CB Therapeutics on Twitter: @CBTherapeutics Follow CB
Therapeutics on Instagram: @cb_thera
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240415387825/en/
Partnership Inquiries: Sher Ali Butt CEO, CB Therapeutics Email:
sher@cbthera.com